Earlier-Line BCMA CAR-T Reduces, but Does Not Eliminate, Hematotoxicity

Institutions: Medical College of Wisconsin / UAMS · Finding: Earlier-Line BCMA CAR-T Reduces Hematotoxicity · Indication: Multiple Myeloma · Publication: Blood Cancer Journal · Date: August 22, 2026 Summary A 245-patient real-world study found that immune effector cell-associated hematotoxicity (ICAHT) after BCMA-directed CAR-T therapy was…